Biotech Fund logo

Biotech Fund

Investing in early stage life science startups

By

As science is democratized, hacking biology is becoming more efficient and accessible. Programming the biological system touches all aspects of life from healthcare to manufacturing to agriculture. The cost of automation, materials, and labor will drop by a step function. 

The future of life sciences will be led by pioneer scientists utilizing technology to make biology move faster, accurately testing more hypotheses per unit time. The foundation of biotech is at an inflection point and our fund managers invest in the scientist founders the traditional funders are neglecting, the scientists working on the problems that will transform how we do biology.

Deal Activity

Expected Deals per Year
Prior Capital Invested

Syndicate Manager

CEO and Cofounder of Wefunder. General Partner of Wefunder Advisors. MBA from Babson. Holds Series 65. Alumni of Y Combinator (W13) and Techstars.

Portfolio

Wefunder logo
Wefunder May 2012